Company / Accounts Receivable
Natera, Inc. Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$296.5M
FY2025
5-year range
$122.1M / $314.2M
FY2021-FY2025
Trend
-5.6%
vs FY2024
Sector context
#60 of 138
Health Care
What the data says
At $297M, Natera, Inc.'s accounts receivable ranks #60 of 138 in the Health Care sector. Accounts Receivable has fluctuated over the past 10 years, ranging from $13M in FY2016 to $314M in FY2024.
Based on SEC 10-K filings.
$297M in FY2025 with a 5-year CAGR of +30.4%.
Improved from $278M to $297M over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +6.7%
- 5-Year CAGR
- +30.4%
- 10-Year CAGR
- -
Sector benchmark
#60 of 138 in Health CareTop 43% of 138This company $296.5M Sector average $1.3B
▼
-77.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +30.4%, indicating consistent growth.
- In FY2025, accounts receivable decreased 5.6% year-over-year.
- Ranks #60 out of 138 companies in the Health Care sector.
- Peak accounts receivable was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -11.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $296.5M | -5.6% |
| FY2024 | $314.2M | +12.9% |
| FY2023 | $278.3M | +13.9% |
| FY2022 | $244.4M | +100.2% |
| FY2021 | $122.1M | +55.4% |
| FY2020 | $78.6M | +47.3% |
| FY2019 | $53.4M | -14.3% |
| FY2018 | $62.2M | +41.1% |
| FY2017 | $44.1M | +229.1% |
| FY2016 | $13.4M | +128.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026